Compare IDEXX Laboratories, Inc. (IDXX) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs PulteGroup, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while PulteGroup, Inc. trades at $112.12 (market cap $21.63B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and PulteGroup, Inc. pays a 0.92% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and PulteGroup, Inc. for 91 Days on average.
| IDXX | PHM | |
|---|---|---|
Market Cap | $40.43B | $21.63B |
Volume | 692,164 | 2,324,729 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $142.56 |
52-Week Low | $504.70 | $110.11 |
Typical Hold Time | 46 Days | 91 Days |
Enterprise Value | $41.32B | $22.04B |
Dividend Yield | — | 0.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
PulteGroup (PHM) trades at $112.12, down 0.19% with a bearish technical outlook. The stock shows mixed fundamentals with recent earnings misses but maintains solid profitability margins. Analyst consensus remains positive with a $139.80 price target, though technical indicators signal selling pressure amid rising mortgage rate concerns affecting the housing sector.
PHM presents value opportunity with attractive P/E of 11.6 and strong cash flow generation, but faces headwinds from rising interest rates impacting housing demand. The stock trades near support at $110 with institutional accumulation providing downside cushion, though sector volatility requires careful risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
